Moderna Announces Successful Trial of Combined Covid and Flu Vaccine, Seeks Regulatory Approval
Monday, 10 June 2024, 10:30
Moderna Reports Positive Trial Results
In a significant development, Moderna has achieved success in combined Covid and flu vaccine trials.
Regulatory Approval Sought
The company is now in the process of seeking regulatory approval for the innovative jab.
This move demonstrates Moderna's commitment to diversifying its product portfolio and addressing multiple health challenges with a single solution.
The successful trial results mark a major milestone for the company and the healthcare industry, showcasing the potential for effective dual-protection against Covid-19 and influenza.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.